CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-01 | Gold Mark Stephen Director | Grant or award · Restricted Stock Units | +6,173 | 6,173 | ||
| 2020-06-01 | NEELS GUIDO J Director | Grant or award · Stock Option (right to purchase) | +16,807 | 16,807 | ||
| 2020-06-01 | NEELS GUIDO J Director | Grant or award · Restricted Stock Units | +4,115 | 4,115 | ||
| 2020-06-01 | Wendell Amy McBride Director | Grant or award · Stock Option (right to purchase) | +16,807 | 16,807 | ||
| 2020-06-01 | Wendell Amy McBride Director | Grant or award · Restricted Stock Units | +4,115 | 4,115 | ||
| 2020-06-01 | Rudelius Robert James Director | Grant or award · Stock Option (right to purchase) | +16,807 | 16,807 | ||
| 2020-06-01 | Rudelius Robert James Director | Grant or award · Restricted Stock Units | +4,115 | 4,115 | ||
| 2020-06-01 | Blackford Quentin S. Director | Grant or award · Stock Option (right to purchase) | +16,807 | 16,807 | ||
| 2020-06-01 | Blackford Quentin S. Director | Grant or award · Restricted Stock Units | +4,115 | 4,115 | ||
| 2020-06-01 | Ottinger Bradley General Counsel and CCO | Grant or award · Employee Stock Option (right to purchase) | +67,000 | 67,000 | ||
| 2020-06-01 | Ottinger Bradley General Counsel and CCO | Grant or award · Restricted Stock Units | +31,000 | 31,000 | ||
| 2020-05-29 | Freitag Gregory Gene General Counsel | Option exercise | +125,000 | $3.50 | $438K | 231,484 |
| 2020-05-29 | Freitag Gregory Gene General Counsel | Option exercise · Employee Stock Option (right to buy) | −125,000 | 0 | ||
| 2020-05-28 | Donovan Michael Patrick VP Operations | Option exercise | +10,000 | $3.67 | $37K | 38,646 |
| 2020-05-28 | Donovan Michael Patrick VP Operations | Option exercise | +5,000 | $5.14 | $26K | 43,646 |
| 2020-05-28 | Donovan Michael Patrick VP Operations | Option exercise · Employee Stock Option (right to buy) | −10,000 | 0 | ||
| 2020-05-28 | Donovan Michael Patrick VP Operations | Option exercise · Employee Stock Option (right to buy) | −5,000 | $5.14 | $26K | 20,000 |
| 2020-04-28 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise | +2,530 | $0.27 | $683 | 51,056 |
| 2020-04-28 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise · Employee Stock Option (right to buy) | +2,530 | 0 | ||
| 2020-04-16 | Zaderej Karen L. CEO | Option exercise | +11,625 | $4.81 | $56K | 658,869 |
Page 43 of 69 · 1,376 trades